logo Click here for the Chao Family Comprehensive Cancer Center Home Page Click here for the UC Irvine Home Page

Chao Lectureship Series

The 15th annual Allen and Lee-Hwa Chao Lectureship in Cancer Research hosts leading cancer researcher, Ronald M. Evans, PhD, on Oct. 22 and 23. 

Evans, a professor and head of the Salk Institute's Gene Expression Laboratory and the March of Dimes Chair in Molecular and Developmental Biology, is world renowned for his seminal research on nuclear hormone receptors, which has led to more than half a dozen drugs for cancer, diabetes and heart disease.


Community lecture
Tuesday, Oct. 22, 2013
Beckman Center, UC Irvine Campus
5 p.m. reception
6 p.m. community lecture
"Understanding Performance: Can Exercise Mimetics Replace Exercise?"

Contact: ChaoLectureRSVP@uadv.uci.edu or 714-456-5800

Scientific lecture
Wednesday, Oct. 23, 2013
Tamkin Lecture Hall (F-110), UC Irvine Campus
12:30 p.m. to1:30 p.m.
"Nuclear Receptors and the Hunger Games: from Feast to Famine"

Contact: CancerCenterRSVP@uci.edu or 714-456-8334

View more information about the lecture series:

About the speaker:

Ronald M. Evans, a professor in the Salk Institute's Gene Expression Laboratory, is the March of Dimes Chair in Developmental and Molecular Biology. He is an authority on the normal activities of hormones and their roles in disease. Evans' lab discovered a large family of molecules, named receptors, that respond to various steroid hormones, Vitamin A and thyroid hormones.

These hormones help control sugar, salt, calcium and fat metabolism; thus, they have an impact on human health and the treatment of disease. The receptors Evans' lab discovered are primary targets in the treatment of breast cancer, prostate cancer and leukemia, as well as osteoporosis and asthma.

Evans' studies also led to a new hormone that appears to be the molecular trigger controlling the formation of fat cells. This hormone and its chemical derivatives represent one of the newest and most important advances in understanding problems arising from excess weight and obesity as well as the potential treatment of adult onset diabetes (Type II diabetes).